Literature DB >> 2494395

Effect of breathing pattern during inhalation challenge on the shape and position of the dose-response curve.

S Guillemi1, A L James, P D Pare.   

Abstract

To examine the effect of breathing pattern on the dose-response curve, 4 mild asthmatic and 9 normal subjects inhaled increasing concentrations of methacholine (0.03-256 mg/ml) using a quiet tidal breathing pattern or tidal breathing with a forced expiratory phase. The provocative concentration of methacholine causing a 20% decrease in the forced expired volume in 1 s (PC20FEV1) or a 200% increase in pulmonary resistance (PC 200RL) was determined. In addition, the maximal change in FEV1 and RL and the slopes of the dose-response curves were measured. The forced expiratory pattern caused an increase in the central/peripheral deposition ratio of a [99m]technetium-labeled aerosol (n = 3). There were no differences in mean tidal volume, minute ventilation, inspiratory flow rates, or baseline FEV1 or RL between the quiet breathing or forced expiration studies, although mean expiratory flows were increased in the latter (p less than 0.001). PC20FEV1 and PC200 RL decreased (p less than 0.001) but the maximal change in FEV1 and RL was unchanged in the forced expiration studies. Forced expiration during inhalation challenge did not alter the slope of FEV1 or RL dose-response curves. These results suggest that the sensitivity (PC20, PC200) and maximal response of in vivo dose-response curves may be affected independently by factors such as aerosol deposition.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2494395     DOI: 10.1007/bf02714936

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  27 in total

1.  Evaluation of airway interruption technique as a method for measuring pulmonary airflow resistance.

Authors:  J MEAD; J L WHITTENBERGER
Journal:  J Appl Physiol       Date:  1954-01       Impact factor: 3.531

Review 2.  Deposition of aerosol in the respiratory tract.

Authors:  J D Brain; P A Valberg
Journal:  Am Rev Respir Dis       Date:  1979-12

3.  Measurement of intrabronchial pressure in man.

Authors:  P T Macklem; N J Wilson
Journal:  J Appl Physiol       Date:  1965-07       Impact factor: 3.531

4.  Variability of airway responsiveness to histamine aerosol in normal subjects. Role of deposition.

Authors:  A Wanner; J M Brodnan; J Perez; K G Henke; C S Kim
Journal:  Am Rev Respir Dis       Date:  1985-01

5.  Factors modulating the interindividual variability of airway responsiveness to histamine. The influence of H1 and H2 receptors.

Authors:  M C Michoud; J Lelorier; R Amyot
Journal:  Bull Eur Physiopathol Respir       Date:  1981

6.  The shape of the dose-response curve to histamine in asthmatic and normal subjects.

Authors:  A J Woolcock; C M Salome; K Yan
Journal:  Am Rev Respir Dis       Date:  1984-07

Review 7.  Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance.

Authors:  F E Hargreave; G Ryan; N C Thomson; P M O'Byrne; K Latimer; E F Juniper; J Dolovich
Journal:  J Allergy Clin Immunol       Date:  1981-11       Impact factor: 10.793

8.  Flow limitation, cough, and patterns of aerosol deposition in humans.

Authors:  G C Smaldone; M S Messina
Journal:  J Appl Physiol (1985)       Date:  1985-08

9.  Standardization of inhalation provocation tests: two techniques of aerosol generation and inhalation compared.

Authors:  G Ryan; M B Dolovich; R S Roberts; P A Frith; E F Juniper; F E Hargreave; M T Newhouse
Journal:  Am Rev Respir Dis       Date:  1981-02

10.  The effects of preferential deposition of histamine in the human airway.

Authors:  R E Ruffin; M B Dolovich; R K Wolff; M T Newhouse
Journal:  Am Rev Respir Dis       Date:  1978-03
View more
  1 in total

1.  Variability of the plateau response to methacholine in subjects without respiratory symptoms.

Authors:  M D Lougheed; G Pearce-Pinto; N H de Klerk; G Ryan; A W Musk; A James
Journal:  Thorax       Date:  1993-05       Impact factor: 9.139

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.